Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
Clinical trial NCT02812706 · COMPLETED
Trial details
- NCT number
- NCT02812706
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-05
- Primary completion
- 2018-07-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.